94198-9

LOINC 2.82

DPYD gene full mutation analysis in Blood or Tissue by Sequencing

DPYD gene Full Mut Anl Bld/T Seq

Definition

  • The test includes full sequence analysis of exons and intron/exon boundaries of all 23 exons in the DPYD gene. Testing may be performed to identifying individuals at increased risk of toxicity when considering 5-fluorouracil (5-FU) and capecitabine chemotherapy treatment. Variations detected in the DPYD gene are also associated with dihydropyrimidine dehydrogenase (DPD) deficiency.

Component

  • DPYD gene full mutation analysis

Specimen / system

  • Bld/Tiss

Class

  • MOLPATH.PHARMG

Property

  • Find

Scale

  • Doc

Method

  • Sequencing

Related names

  • Blood; DHP; DHPDHase; dihydropyrimidine dehydrogenase; Dihydropyrimidine dehydrogenase gene; Dihydrothymine dehydrogenase gene; Dihydrouracil dehydrogenase gene; Document; DPD; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue

Index terms

  • Blood
  • DHP
  • DHPDHase
  • dihydropyrimidine dehydrogenase
  • Dihydropyrimidine dehydrogenase gene
  • Dihydrothymine dehydrogenase gene
  • Dihydrouracil dehydrogenase gene
  • Document
  • DPD
  • Finding
  • Findings
  • full gene sequencing
  • Full Mut Anl
  • Genetics
  • Heredity
  • Heritable
  • high-throughput sequencing
  • HTS
  • Inherited
  • Molecular pathology
  • MOLPATH
  • MOLPATH.PHARMG
  • Mut
  • Mutations
  • Next generation sequencing
  • NGS
  • Point in time
  • Random
  • sequencing of entire coding region
  • Tissue
  • Tissue, unspecified
  • WB
  • Whole blood
  • Whole blood or Tissue